NIM
ONC

NEOS Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

NEOS Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,187
Closed -$2.49M – 664
2025
Q4 		$2.49M Buy
8,187
+1,416
+21% +$463K 0.01% 444
2025
Q3 		$2.31M Sell
6,771
-936
-12% -$284K 0.02% 422
2025
Q2 		$1.87M Buy
7,707
+624
+9% +$153K 0.02% 383
2025
Q1 		$1.93M Buy
7,083
+834
+13% +$195K 0.04% 328
2024
Q4 		$1.15M Sell
6,249
-189
-3% -$38.6K 0.03% 379
2024
Q3 		$1.45M Buy
6,438
+407
+7% +$73.2K 0.04% 316
2024
Q2 		$860K Buy
6,031
+3,515
+140% +$542K 0.04% 356
2024
Q1 		$393K Buy
2,516
+74
+3% +$11.9K 0.02% 443
2023
Q4 		$440K Buy
+2,442
New +$442K 0.04% 309

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NEOS Investment Management's ONC Position: Q1 2026 in Review

NEOS Investment Management sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 8,187 shares — an estimated $2.49M sold.

NEOS Investment Management first reported a position in ONC in Q4 2023 and held it in 9 quarters. The position peaked at $2.49M in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • NEOS Investment Management reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 8,187 BeOne Medicines Ltd shares in Q1 2026, an estimated $2.49M.
  • NEOS Investment Management first reported a position in BeOne Medicines Ltd in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's BeOne Medicines Ltd position peaked at $2.49M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.